Amplifier Therapeutics

About:

Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules.

Website: https://www.amplifier-tx.com

Top Investors: Cambrian Biopharma, RA Capital Management, Future Ventures

Description:

Amplifier Therapeutics is a biopharmaceutical firm, developing AMP-activated protein kinase (AMPK) activator molecules to treat aging-related disorders such as metabolic problems, cardiovascular diseases, kidney diseases, and cancer.

Total Funding Amount:

$33.3M

Headquarters Location:

New York, New York, United States

Founded Date:

2001-01-01

Founders:

Helena Edlund, Thomas Edlund

Number of Employees:

11-50

Last Funding Date:

2023-10-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai